Trials / Terminated
TerminatedNCT00845845
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current pilot study assesses the use of magnetic resonance imaging (MRI) to quantify hepatic steatosis. It will provide preliminary data regarding the use of omega-3 fatty acid supplementation (Lovaza) for the treatment of nonalcoholic steatohepatitis (NASH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omega-3-acid ethyl esters (Lovaza) | 4 milligrams daily omega-3-acid ethyl esters (Lovaza) with dietary counseling for 24 weeks. |
| DRUG | Placebo | Daily placebo with dietary counseling for 24 weeks. |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-02-18
- Last updated
- 2013-07-24
- Results posted
- 2013-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00845845. Inclusion in this directory is not an endorsement.